Invited Commentary
Multiparametric Magnetic Resonance Imaging to Monitor Pediatric Liver Disease
Looks Interesting but More Work to Do
Patrick J. McKiernan,
Corresponding Author
Patrick J. McKiernan
Division of Gastroenterology, Hepatology and Nutrition, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
Address correspondence and reprint requests to Patrick J. McKiernan, MD, Division of Gastroenterology, Hepatology and Nutrition, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224 (e-mail:
[email protected]).
Search for more papers by this author
Patrick J. McKiernan,
Corresponding Author
Patrick J. McKiernan
Division of Gastroenterology, Hepatology and Nutrition, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
Address correspondence and reprint requests to Patrick J. McKiernan, MD, Division of Gastroenterology, Hepatology and Nutrition, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224 (e-mail:
[email protected]).
Search for more papers by this author
First published: 21 September 2020
No abstract is available for this article.
REFERENCES
- 1.Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology 2020; 72: 671–722.
- 2.Mieli-Vergani G, Vergani D, Baumann U, et al. Diagnosis and management of paediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement. J Pediatr Gastroenterol Nutr 2018; 66: 345–360.
- 3.Di Giorgio A, Hadzic N, Dhawan A, et al. Seamless management of juvenile autoimmune liver disease: long-term medical and social outcome. J Pediatr 2020; 218: 121.e3–129.e3.
- 4.Luth S, Herkel J, Kanzler S, et al. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. J Clin Gastroenterol 2008; 42: 926–930.
- 5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: autoimmune hepatitis. J Hepatol 2015; 63: 971–1004.
- 6.Soloway RD, Summerskill WH, Baggenstoss AH, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972; 63: 820–833.
- 7.Hartl J, Ehlken H, Sebode M, et al. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. J Hepatol 2018; 68: 754–763.
- 8.Janowski K, Shumbayawonda E, Dennis A, et al. Multiparametric MRI as a noninvasive monitoring tool for children with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 2021; 72: 108–114.
- 9.Pavlides M, Banerjee R, Sellwood J, et al. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol 2016; 64: 308–315.
- 10.Pavlides M, Banerjee R, Tunnicliffe EM, et al. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int 2017; 37: 1065–1073.
